Alnylam Pharmaceuticals ALNY
NASDAQ ALNY
$255.36 -0.60 (-0.23%)
At close: Sep 28, 2026 · 4:00 PM EDT

Alnylam Pharmaceuticals (ALNY) Receivables (2009 - 2026)

Updated

Alnylam Pharmaceuticals (ALNY) posted Receivables of $912.74 million for Q2 2026, up 60.9% from $567.11 million a year earlier and up 3.3% from the prior quarter.

Analysis

Alnylam Pharmaceuticals (ALNY) Receivables (2009 - 2026) Analysis & Trends

At the end of FY2025, Alnylam Pharmaceuticals' Receivables came in at $777.57 million, up 91.8% from FY2024.

  • Annual Receivables has increased for four consecutive years, with a five-year compound annual growth rate of 5.2% (FY2020 to FY2025).
  • In prior years, Alnylam Pharmaceuticals' Receivables was $405.31 million in FY2024 (+23.6%), $327.79 million in FY2023 (+37.7%), $237.96 million in FY2022 (+19.8%) and $198.57 million in FY2021 (-67.0%).
  • Quarterly Receivables has run from a low of $141.06 million in Q3 2021 to a high of $964.77 million in Q3 2025 over five years.
  • On a year-over-year basis, Receivables has increased in each of the last 16 quarters, with growth averaging 72.8% over the last eight quarters.
  • The strongest year-over-year quarter for Receivables in the past five years was Q3 2025, with growth of 172.6%; the weakest was Q2 2022, with a decline of 78.0%.
  • According to Business Quant data, Receivables for the three prior quarters was $883.96 million (Q1 2026), $777.57 million (Q4 2025) and $964.77 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn 19.05 Bn
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn 13.82 Bn
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn 15.68 Bn
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn 2.13 Bn
10 Alnylam Pharmaceuticals 34.23 Bn 22.28 Bn 992.69 Mn 912.74 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 912.74 Mn
Mar 31, 2026 883.96 Mn
Dec 31, 2025 777.57 Mn
Sep 30, 2025 964.77 Mn
Jun 30, 2025 567.11 Mn
Mar 31, 2025 418.04 Mn
Dec 31, 2024 405.31 Mn
Sep 30, 2024 353.85 Mn
Jun 30, 2024 309.48 Mn
Mar 31, 2024 321.38 Mn
Dec 31, 2023 327.79 Mn
Sep 30, 2023 325.45 Mn
Jun 30, 2023 220.64 Mn
Mar 31, 2023 219.43 Mn
Dec 31, 2022 237.96 Mn
Sep 30, 2022 184.51 Mn
Jun 30, 2022 142.27 Mn
Mar 31, 2022 156.53 Mn
Dec 31, 2021 198.57 Mn
Sep 30, 2021 141.06 Mn
API Access

Alnylam Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=ALNY&period=max&api_key=YOUR_API_KEY